GTR Test Accession:
Help
GTR000569049.3
NYS CLEP
CAP
Last updated in GTR:
2024-08-30
View version history
GTR000569049.3,
last updated:
2024-08-30
GTR000569049.2,
last updated:
2023-08-30
GTR000569049.1,
registered in GTR:
2022-08-30
Last annual review date for the lab: 2024-08-30
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Predictive; ...
Conditions (19):
Help
Hypercholesterolemia, familial, 1;
Aneurysm-osteoarthritis syndrome;
Aortic aneurysm, familial thoracic, SMAD3 related
more...
Genes (30):
Help
Methods (1):
Help
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Target population: Help
Individuals with or without family history of cardiovascular disease or …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
Cardio
Specimen Source:
Help
- Peripheral (whole) blood
- Saliva
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
- Nurse Practitioner
Contact Policy:
Help
Post-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
How to Order:
Help
Please see Color website for ordering details (https://www.color.com/).
Order URL
Order URL
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Confirmation of research findings
Custom Deletion/Duplication Testing
Custom Sequence Analysis
Genetic counseling
Result interpretation
Confirmation of research findings
Custom Deletion/Duplication Testing
Custom Sequence Analysis
Genetic counseling
Result interpretation
Test development:
Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test Order Code,
Lab contact for this test,
Test strategy
Conditions
Help
Total conditions: 19
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 30
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Other
Clinical Information
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Predictive;
Risk Assessment;
Screening
Target population:
Help
Individuals with or without family history of cardiovascular disease or familial hypercholesterolemia interested in knowing about their genetic risk for disease.
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
Decline to answer.
Decline to answer.
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Yes. As part of the Color service, we will attempt to recontact the provider and/or the person that was tested with any clinically significant updates to the reported results.
Yes. As part of the Color service, we will attempt to recontact the provider and/or the person that was tested with any clinically significant updates to the reported results.
Recommended fields not provided:
Clinical validity,
Clinical utility,
What is the protocol for interpreting a variation as a VUS?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
Genomic DNA is extracted from the submitted sample, enriched for select regions using a hybridization protocol, and sequenced using Illumina Next Generation Sequencing. Sequence data is aligned to a reference genome, and variants are identified using a suite of bioinformatic tools designed to detect single nucleotide variants, small insertions/deletions, copy …
View more
Test Confirmation:
Help
Likely pathogenic and pathogenic variants, including single nucleotide variants, insertions and deletions, and structural variants, are confirmed by an alternative technology according to Color’s internal protocols. Certain exceptions apply: variants will not be confirmed if, after testing, there is insufficient DNA available for secondary confirmation, and variants called at high …
View more
Test Comments:
Help
ACTA2, ACTC1, APOB, COL3A1, DSC2, DSG2, DSP, FBN1, GLA, KCNH2, KCNQ1, LDLR, LMNA, MYBPC3, MYH11, MYH7, MYL2, MYL3, PCSK9, PKP2, PRKAG2, RYR2, SCN5A, SMAD3, TGFBR1, TGFBR2, TMEM43, TNNI3, TNNT2, TPM1
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
This test detects single nucleotide substitutions, small deletions and insertions, copy number variations, inversions, and mobile element insertions located in the DNA coding sequences, nearby flanking regions and known splice regions in the genes targeted by the Color panel. Our median coverage across our samples is >250X and our minimum …
View more
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
Not Applicable
NYS CLEP Approval:
Help
Number:
69579
Status: Approved
Status: Approved
Additional Information
Clinical resources:
Practice guidelines:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.